VivoSim Labs Chairman Urges FDA to Advance Non-Animal Testing Guidance

Executive Chairman Keith Murphy is urging the FDA to identify and qualify non-animal models for use in Investigational New Drug applications, following a September 2026 rule change permitting non-animal drug-safety testing methods.